MICU2上调增强瘤的攻击性和在结直肠癌发育期间的代谢重编程
Alison Robert1, David Crottès1, Jérôme Bourgeais1
1UMR Inserm 1069 N2COx « Niche, Nutrition, Cancer et métabolisme Oxydatif », Tours University, Tours, France.
PLoS biology
|October 28, 2024
概括
线粒体吸收2 (MICU2) 对结直肠癌 (CRC) 细胞生长和侵入至关重要. 它在先进的CRC中表达的增加凸显了它在癌症进展和代谢重编程中的作用.
科学领域:
- 线粒体生物学 线粒体生物学
- 癌症研究 癌症研究
- 细胞代谢 细胞代谢
背景情况:
- 线粒体单载体 (MCU) 调节线粒体吸收,影响氧化代谢.
- 形成MCU孔隙的蛋白质与癌症有关,但MICU1和MICU2等调节性蛋白质的理解较少.
- 线粒体吸收1 (MICU1) 和线粒体吸收2 (MICU2) 是MCU复合体的调节子单元.
研究的目的:
- 研究MICU2在结直肠癌 (CRC) 细胞增殖和侵入中的作用.
- 分析晚期CRC和转移中的MICU2表达模式.
- 阐明MICU1和MICU2在癌症代谢中的功能相互作用.
主要方法:
- 人体结直肠癌 (CRC) 的体外和体内模型.
- 转录组分析以评估MICU2和MICU1的表达.
- 评估线粒体吸收和线粒体网络完整性.
- 分析糖解和氧化酸化 (OXPHOS) 之间的代谢灵活性.
主要成果:
- 在先进的CRC和转移中,MICU2表达和MICU2/MICU1比率升高.
- MICU2表达对线粒体吸收和维护线粒体网络质量至关重要.
- MICU2和MICU1的相互作用影响了代谢灵活性,影响了糖解和OXPHOS之间的平衡.
结论:
- MICU2在结直肠癌细胞扩散和入侵中发挥着重要作用.
- 晚期CRC中MICU2表达升高表明它与疾病进展有关.
- MICU复合体 (MICU1和MICU2) 涉及与癌症相关的代谢重编程.
更多相关视频
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.0K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
